Literature DB >> 16864723

Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction.

Toshiyuki Takahashi1, Tong Tang, N Chin Lai, David M Roth, Brian Rebolledo, Miho Saito, Wilbur Y W Lew, Paul Clopton, H Kirk Hammond.   

Abstract

BACKGROUND: Cardiac-directed expression of adenylyl cyclase type VI (AC(VI)) in mice results in structurally normal hearts with normal basal heart rate and function but increased responses to catecholamine stimulation. We tested the hypothesis that increased left ventricular (LV) AC(VI) content would increase mortality after acute myocardial infarction (MI). METHODS AND
RESULTS: Transgenic mice with cardiac-directed AC(VI) expression and their transgene-negative littermates (control) underwent coronary ligation, and survival, infarct size, and LV size and function were assessed 1 to 7 days after MI. Mice with increased AC(VI) expression had increased survival (control 41%, AC(VI) 74%; P = 0.004). Infarct size and myocardial apoptotic rates were similar in AC(VI) and control mice; however, AC(VI) mice had less LV dilation (P < 0.001) and increased ejection fractions (P < 0.03). Three days after MI, studies in isolated perfused hearts showed that basal LV +dP/dt was similar, but graded dobutamine infusion was associated with a more robust LV contractile response in AC(VI) mice (P < 0.05). Increased LV function was associated with increases in cAMP generation (P = 0.0002), phospholamban phosphorylation (P < 0.04), sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) affinity for calcium (P < 0.015), and reduced AV block (P = 0.04).
CONCLUSIONS: In acute MI, increased cardiac AC(VI) content attenuates adverse LV remodeling, preserves LV contractile function, and reduces mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864723     DOI: 10.1161/CIRCULATIONAHA.106.632513

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  52 in total

1.  Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload.

Authors:  Aziz Guellich; Shumin Gao; Chull Hong; Lin Yan; Thomas E Wagner; Sunil K Dhar; Bijan Ghaleh; Luc Hittinger; Kosaku Iwatsubo; Yoshihiro Ishikawa; Stephen F Vatner; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-18       Impact factor: 4.733

Review 2.  Prospects for gene transfer for clinical heart failure.

Authors:  T Tang; M H Gao; H Kirk Hammond
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

3.  Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice.

Authors:  Tong Tang; N Chin Lai; H Kirk Hammond; David M Roth; Yuan Yang; Tracy Guo; Mei Hua Gao
Journal:  J Am Coll Cardiol       Date:  2010-04-06       Impact factor: 24.094

Review 4.  Gene therapy in heart failure.

Authors:  Leif Erik Vinge; Philip W Raake; Walter J Koch
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

Review 5.  Gene therapy targets in heart failure: the path to translation.

Authors:  P W J Raake; H Tscheschner; J Reinkober; J Ritterhoff; H A Katus; W J Koch; P Most
Journal:  Clin Pharmacol Ther       Date:  2011-08-24       Impact factor: 6.875

Review 6.  Cyclic AMP synthesis and hydrolysis in the normal and failing heart.

Authors:  Aziz Guellich; Hind Mehel; Rodolphe Fischmeister
Journal:  Pflugers Arch       Date:  2014-04-24       Impact factor: 3.657

7.  Injectable Drug-Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction.

Authors:  Jun Fang; Jaekyung Koh; Qizhi Fang; Huiliang Qiu; Maani M Archang; Mohammad Mahdi Hasani-Sadrabadi; Hiromi Miwa; Xintong Zhong; Richard Sievers; Dong-Wei Gao; Randall Lee; Dino Di Carlo; Song Li
Journal:  Adv Funct Mater       Date:  2020-09-06       Impact factor: 18.808

8.  Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart.

Authors:  Zhenghang Zhao; Gopal J Babu; Hairuo Wen; Nadezhda Fefelova; Richard Gordan; Xiangzhen Sui; Lin Yan; Dorothy E Vatner; Stephen F Vatner; Lai-Hua Xie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

9.  Adenylyl cyclase 6 deletion increases mortality during sustained β-adrenergic receptor stimulation.

Authors:  Tong Tang; N Chin Lai; Adam T Wright; Mei Hua Gao; Paul Lee; Tracy Guo; Ruoying Tang; Andrew D McCulloch; H Kirk Hammond
Journal:  J Mol Cell Cardiol       Date:  2013-04-12       Impact factor: 5.000

10.  beta(1)-Adrenergic receptor vs adenylyl cyclase 6 expression in cardiac myocytes: differences in transgene localization and intracellular signaling.

Authors:  Mei Hua Gao; Tong Tang; Atsushi Miyanohara; James R Feramisco; H Kirk Hammond
Journal:  Cell Signal       Date:  2009-11-20       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.